Novel Immune Targets in Melanoma—Response

Novel Immune Targets in Melanoma—Response.

Full text not available from this repository.
Item Type: Article
Status: Published
Official URL: https://doi.org/10.1158/1078-0432.CCR-19-1866
Journal or Publication Title: Clinical Cancer Research
Volume: 25
Number: 17
Page Range: pp. 5424-5425
Date: 2019
Divisions: Human Viral and Cancer Immunology
Depositing User: General Admin
Identification Number: 10.1158/1078-0432.CCR-19-1866
ISSN: 1078-0432
Date Deposited: 21 Dec 2020 05:47
Abstract:

No abstract available.

Editorial comment on: Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials. Tasker et al Clin Cancer Res. 2019 Jun 1;25(11):3247-3258. doi: 10.1158/1078-0432.CCR-18-4011.
and
Novel Immune Targets in Melanoma-Letter. Nocentini G, Cari L, Riccardi C.: Clin Cancer Res. 2019 Sep 1;25(17):5422-5423. doi: 10.1158/1078-0432.CCR-19-1140.

Creators:
Creators
Email
Edwards, Jarem
UNSPECIFIED
Batten, Marcel
UNSPECIFIED
Ferguson, Angela
UNSPECIFIED
Palendira, Umaimainthan
UNSPECIFIED
Wilmott, James S.
UNSPECIFIED
Long, Georgina V.
UNSPECIFIED
Scolyer, Richard A.
UNSPECIFIED
Last Modified: 21 Dec 2020 05:47
URI: https://eprints.centenary.org.au/id/eprint/355

Actions (login required)

View Item View Item